Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents

DS Hawkins, GW Demers, DA Galloway - Cancer research, 1996 - AACR
Many tumor types have p53 and/or RB mutations, and it is unclear what role the mutations of
these tumor suppressor genes have on the efficacy of chemotherapeutic agents. The effect …
被引用次数：441 相关文章

Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents

DS Hawkins, GW Demers, DA Galloway - Cancer Research, 1996 - hero.epa.gov
Many tumor types have p53 and/or RB mutations, and it is unclear what role the mutations of
these tumor suppressor genes have on the efficacy of chemotherapeutic agents. The effect …

Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents

DS Hawkins, GW Demers… - Cancer …, 1996 - pubmed.ncbi.nlm.nih.gov
Many tumor types have p53 and/or RB mutations, and it is unclear what role the mutations of
these tumor suppressor genes have on the efficacy of chemotherapeutic agents. The effect …

[引用][C] Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents

D HAWKINS - Cancer Res, 1996 - cir.nii.ac.jp

Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents.

DS Hawkins, GW Demers, DA Galloway - Cancer Research, 1996 - europepmc.org
Many tumor types have p53 and/or RB mutations, and it is unclear what role the mutations of
these tumor suppressor genes have on the efficacy of chemotherapeutic agents. The effect …

[引用][C] Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents

DS HAWKINS, GW DEMERS… - Cancer research …, 1996 - pascal-francis.inist.fr
Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …